Sitagliptin and Kinetics of Triglyceride-rich Lipoproteins Apolipoprotein B48 and B100 in Patients With Type 2 Diabetes (JANUB48)
This study has been completed.
First Posted: April 13, 2011
Last Update Posted: April 4, 2016
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Patrick Couture, Laval University